FRANCE – As a stable of new players sets out to topple Dupixent’s status as the reigning antibody treatment for atopic dermatitis, the blockbuster’s developers are moving the goalposts. Dupixent…
Read MoreSanofi, Regeneron burnish their blockbuster Dupixent franchise
